Sustainability Investors Products Research & Development Company Contact
Sustainability
ESG Environment Social
Investors
Reasons to invest Share information News Reports Corporate governance Stock exchange notices
Products
Salmon protein hydrolysate Salmon oil Calcium bone powder Collagen peptides European webshops
Research & Development
Our research All research programs Studies
Company
About us Our technology Operations Management Board of directors
Contact
Management Sales Investor relations
Type and search

All notices

Hofseth BioCare - Invitation to presentation of 2nd quarter 2012 results

17.08.2012

HBC - Blackmores apply omeGO in development of new Omega-3 product

09.08.2012

Hofseth BioCare - Change in financial calendar

27.07.2012

HBC - Signed loan-agreements for refinancing

22.06.2012

HBC - Transferred 5,294 own shares to own accounts

22.06.2012

HBC - Magne Aarsnes allocated 309 shares

22.06.2012

Hofseth BioCare - Annual overview

19.06.2012

HBC - MANDATORY NOTIFICATION OF TRADE

04.06.2012

HBC - MANDATORY NOTIFICATION OF TRADE

01.06.2012

HBC - Breakthrough contract for SPH in the US market

01.06.2012

Previous
22 23 24
25
26 27 28
Next
Sustainability
ESG Environment Social
Investors
Reasons to invest Share information News Reports Corporate governance Stock exchange notices
Products
Salmon protein hydrolysate Salmon oil Calcium bone powder Collagen peptides European webshops
Research & Development
Our research All research programs Studies
Company
About us Our technology Operations Management Board of directors
Contact
Management Sales Investor relations

Copyright 2021 Hofseth BioCare ASA
Privacy cookies